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Endonucleases for apurinic sites as well as chemical compounds reacting with aldehydes do not generally 
differentiate between apurinic and apyrimidinic sites. We have studied the effect of the apurinic site reagent, 
Y-NH,-ellipticine, on apyrimidinic sites enzymatically generated on PBR322 DNA and compared it to its’ 
action on apurinic PM2 and PBR322 DNAs. In conditions where this compound induces breakage of apu- 
rinic sites, it does not display any action on apyrimidinic sites. 
Apyrimidinic site Apurinic site 
1. INTRODUCTION 
The N-glycosidic bond between bases and deox- 
yribose in DNA can be either spontaneously 
broken by base damage or radiation or en- 
zymatically hydrolysed by repair enzymes such as 
glycosidases. The sites generated are named 
apurinic or apyrimidinic according to the excised 
base and are mutagenic and toxic in bacteria [1,2] 
and in mammalian cells [3]. They might constitute 
an intermediate in chemical mutagenesis [4]. The 
DNA intercalating agent, 9-NHz-ellipticine, is 
already known to induce breakage of DNA at 
apurinic sites at a low dose [5]. To measure its ac- 
tion on apyrimidinic sites induced by E. coli uracil- 
DNA glycosidase we have chosen a PBR322* DNA 
from a mutant E. coli strain, containing some 
uracil which have been substituted for thymines 
[6], as a model substrate. For comparison with 
breakage at heat induced apurinic sites we have 
used PM2 DNA as already described in the 
literature [7,14]. However a similar effect is 
observed with apurinic PBR322* DNA. We con- 
firm that the tripeptide Lys-Trp-Lys and E. coli ex- 
Abbreviation: PBR322* DNA, PBR322* DNA with 
uracil substituted thymines 
DNA structure Ellipticine 
onuclease III induce breakage of DNA at 
apyrimidinic sites whereas 9-NH*-ellipticine has no 
effect. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
9-NHz-ellipticine was synthesized by Dr Vie1 
(Chatenay-Malabry) according to a published 
method [S]. Adenine, guanine, cytosine, thymine 
and uracil were from Sigma. [6-3H]Uridine 
(24.3 Ci/mmol) was from NEN (Boston). 
2.2. Nucleic acids 
PBR322 plasmidic DNA was from Boehringer 
(Grenoble). The first steps in the preparation of 
uracil containing PBR322* DNA were performed 
according to a published protocol [6] starting with 
the following strain: E. coli KL 16 (thi-, icl A) [6] 
deficient in uracil-DNA glycosidase (ung muta- 
tion) and in deoxyuridine triphosphatase (dut 
mutation). However, a few steps of additional 
purification were necessary: DNA was treated for 
2 h at 37°C with pancreatic RNase at 50 pg/ml in 
order to obtain an efficient removal of any possi- 
ble RNA contamination. RNase was eliminated 
through a treatment with proteinase K 1 mg/ml, 
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for 12 h at 37”C, followed by 2 phenol extractions. 2.7. Background breakage on control PBR322* 
PM2 DNA was purchased from Boehringer 
(Mannheim) and purified by alcohol precipitation. 
DNA 
2.3. Heat depurination of DNA 
Circular DNAs were depurinated by heating at 
70°C for 7 min (PM2) or 15 min (PBR322) at pH 
5 in 25 mM sodium acetate, acetic acid. 
2.4. Quantification of uracil incorporated into 
PBR322 * DNA 
Uracil containing PBR322* DNA as well as con- 
trol PBR322 DNA were hydrolysed by 1 M per- 
chloric acid at 100°C for 1 h [9]. Analysis of bases 
was then performed in high-performance liquid 
chromatography on a C 18 microbondapak reverse- 
phase column (Waters, Millipore) with the follow- 
ing buffer: 2% methanol, 98% of 50 mM 
NH~HzPO~, pH 4. The different peaks were iden- 
tified through comparison with pure bases injected 
with the hydrolysate. Fractions were collected 
every 30 s and the radioactivity measured by scin- 
tillation counting. 
The amount of 3H cpm in the fraction cor- 
responding to uracil in HPLC after hydrolysis of 
DNA (cf. section 2.4) as well as absorbance 
measurements indicate 40 uracil residues per 
molecule of PBR322* DNA (4% of thymines are 
substituted). The background effects of 
9-NHz-ellipticine and exonuclease III on this DNA 
are unexpected (for conditions see section 3). They 
induce 0.3 breaks per DNA molecule after 2 h at 
37°C whereas no breakage is detected in control 
PBR322. 
2.8. Action of purified E. coli uracil-DNA 
glycosidase on PBR322 * 
2.5. PBR322* DNA treatment by uracil-DNA 
glycosidase 
Uracil-DNA glycosidase from E. coli was 
purified by J.P. Leblanc according to the method 
of Lindahl [lo]. 1.8 pg of DNA was mixed with 
2~1 of purified enzyme in the following buffer: 
7 mM Hepes NaOH, 37.5 mM NaCl, 2 mM 
EDTA, 5 mM dithiothreitol, pH 6.8. Total volume 
was 30~1. The reaction was stopped after a given 
reaction time by addition of 0.3 mM uracil. DNA 
was then alcohol precipitated and resuspended 
either in 1 mM sodium cacodylate, 0.1 mM 
EDTA, pH 7, for treatment with 9-NHz-ellipticine 
or the tripeptide Lys-Trp-Lys (Serva, Heidelberg) 
and with 0.15 M NaCl, 0.015 M sodium citrate, 
0.005 M CaClz for treatment with exonuclease III 
(BRL Bethesda). 
The activity of E. coli uracil-DNA glycosidase 
on PBR322*, measured by alcohol soluble radioac- 
tivity is low. This has already been observed by 
Martin and Sicard [6] according to the number of 
alkali sensitive sites created. In order to correct for 
unspecific effects caused by adsorption of 
[3H]uracil on the tube surface, control experiments 
were performed with an inhibitor of uracil-DNA 
glycosidase, uracil, at a concentration of 0.3 mM 
(KI = 0.1 mM [lo]). A relative 2.5 times increase 
in alcohol soluble radioactivity was then measured 
after 30 min of contact with active uracil-DNA 
glycosidase (10 uracil residues per molecule of 
PBR322 excised). 
3. RESULTS AND DISCUSSION 
The activity of uracil-DNA glycosydase was con- 
trolled through the excision of [14C]uracil on PBS1 
DNA [ll]. 
2.6. Quantification of breakage on DNA 
The breaks were displayed thanks to the relaxa- 
tion of DNA form 1 caused by one single strand 
break. DNA form 2 and form 1 were separated by 
gel electrophoresis and the number of breaks quan- 
tified according to a published method [12]. 
We have compared the action of 
9-NHz-ellipticine, Lys-Trp-Lys and E. coli ex- 
onuclease III on apurinic and apyrimidinic sites. 
Lys-Trp-Lys (1 mM, 2 h at 37°C) and E. coli ex- 
onuclease III (3 units/pg of DNA, 2 h at 37°C) 
cause the same amount of breaks as 
9-NHz-ellipticine (1 yM, 2 h at 37°C) on PM2 
DNAs with different numbers of apurinic sites 
caused by heating (fig.1). In the same conditions 
9-NHz-ellipticine induces the same level of 
breakage as exonuclease III on apurinic PBR322 
DNA (cf. fig.1) and no breaks in control PBR322 
DNA. Experiments were then performed with 2 
different preparations of apyrimidinic PBR322*. 
The effect of 9-NH2-ellipticine was compared to 
exonuclease III on the first preparation, and to 
Lys-Trp-Lys on the second one. Exonuclease III, 
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BREAKS PER MOLECULE OF DNA 
WITH LYS-TRYP-LYS AND 
EXONUCLEASE III 
Fig. 1. Relationship between breakage by 
9-NHz-ellipticine on one hand, Lys-Trp-Lys and E. co/i 
exonuclease III on the other, on DNAs with various 
amounts of apurinic sites and apyrimidinic sites. (D) 
Lys-Trp-Lys on apurinic PM2 DNA; (v) exonuclease III 
on apurinic PM2 DNA; (0) exonuclease III on apurinic 
PBR322 DNA; (v) exonuclease III on apyrimidinic 
PBR322* DNA; (0) Lys-Trp-Lys on apyrimidinic 
PBR322* DNA. All treatments are performed for 2 h at 
37°C. For each substrate, breakage obtained with 
9-NH*-ellipticine (10e6 M) is plotted against breakage 
obtained with Lys-Trp-Lys (10d3 M) or exonuclease III 
(3 units per pug of DNA). For all values background 
breakage is subtracted. 
with Ca2+ instead of Mg’+ [13] and Lys-Trp-Lys 
induce a number of breaks related to 
depyrimidination time whereas breakage caused by 
9-NHz-ellipticine occurs at a background level 
(fig. 1). 
No specificity is known for chemicals breaking 
DNA at apurinic sites. The tripeptide Lys-Trp-Lys 
has thus been shown to break DNA at apurinic 
sites [14,15] and then at apyrimidinic sites [ 161. 
Likewise endonucleases for apurinic sites are 
reported not to be specific, except E. coli en- 
donuclease VII which is specific for apyrimidinic 
sites [17]. 
It may be suggested that heat induced apurinic 
sites are in partially single-stranded DNA [ 181. 
However 2 results [5] indicate that 9-NHz-ellip- 
ticine induces breakage of apurinic sites in double- 
stranded DNA: (i) acido-soluble fragments are 
generated in double-stranded apurinic E. coli 
DNA, (ii) ethidium bromide relaxed apurinic cir- 
cular PM2 DNA is nicked by 9-NHz-ellipticine. By 
another method, a CPK model of a double- 
stranded oligonucleotide clearly indicates that an 
apurinic site is perfectly adapted for a partial inser- 
tion of 9-NHz-ellipticine via the small groove 
whereas it is impossible for an apyrimidinic site. 
This interaction is not possible in double-stranded 
DNA because of steric hindrance and therefore no 
breakage occurs. 
ACKNOWLEDGEMENTS 
We thank Dr J. Lava1 for the gift of E. cofi 
uracil-DNA glycosidase, Dr B. Martin (Toulouse) 
for the gift of the E. coli mutant KL16 strain and 
Professor C. Paoletti for helpful discussions. 
REFERENCES 
111 
121 
[31 
141 
PI 
El 
[71 
PI 
[91 
[lOI 
(111 
WI 
v31 
1141 
[151 
1161 
1171 
U81 
Lawley, P.D. and Martin, C.N. (1975) Biochem. J. 
145, 85-91. 
Kunkel, T.A., Shearman, C.W. and Loeb, L.A. 
(1981) Nature 291, 349-351. 
Gentil, A., Margot, A. and Sarasin, A. (1984) 
Mutat. Res. 129, 141-147. 
Loeb, L.A. (1985) Cell 40, 483-484. 
Malvy, C., Prevost, P., Gansser, C., Viel, C. and 
Paoletti, C. (1986) Chem. Biol. Inter. 57, 41-53. 
Martin, B. and Sicard, N. (1984) Mutat. Res. 132, 
87-93. 
Lindahl, T. and Andersson, A. (1972) Biochemistry 
19, 3618-3623. 
Gansser, C., Viel, C., Malvy, C. and Cros, S. 
(1980) Farmaco 11, 887-895. 
Montesano, R., Bartsch, H. and Tomatis, L. (1976) 
Screening Tests in Chemical Carcinogenesis. IARC 
Scientific Publication no. 12, 187. 
Lindahl, T., Ljungquist, S., Siegert, W., Nyberg, 
B. and Sperens, B. (1977) J. Biol. Chem. 252, 
3286-3293. 
Friedberg, E.C., Ganesan, A.K. and Minton, K. 
(1975) J. Virol. 16, 315-321. 
Malvy, C. (1984) Anal. Biochem. 143, 158-162. 
Gossard, F. and Verly, W.G. (1978) Eur. J. Bio- 
them. 82, 321-332. 
Pierre, J. and Laval, J. (1981) J. Biol. Chem. 256, 
10217-10220. 
Behmoaras, T., Toulme, J.J. and Helene, C. (1981) 
Proc. Natl. Acad. Sci. USA 78, 926-930. 
Duker, N.J. and Hart, D.M. (1982) BBRC 105, 
1433-1439. 
Bonura, T., Schultz, R. and Friedberg, E.C. (1982) 
Biochemistry 21, 2548-2556. 
Lindahl, T. and Nyberg, B. (1972) Biochemistry 11, 
3610-3618. 
157 
